Oxiracetam-13C2,15N is a modified form of Oxiracetam, a popular nootropic compound that is known for its cognitive enhancing effects. This new form of Oxiracetam is labeled with isotopes of carbon and nitrogen, which allows researchers to track its distribution and metabolism within the body.
Oxiracetam-13C2,15N is believed to work by increasing the production and release of acetylcholine, a neurotransmitter that plays a crucial role in cognitive function. It is also thought to enhance the activity of glutamate, a neurotransmitter that is involved in learning and memory.
The unique labeling of Oxiracetam-13C2,15N allows researchers to track its distribution and metabolism within the body, which can provide valuable insight into how the compound is utilized by the brain. This information can help researchers to better understand the mechanisms underlying the cognitive enhancing effects of Oxiracetam, and may lead to the development of even more effective nootropic compounds in the future.
In terms of usage, Oxiracetam-13C2,15N is primarily used in research settings to study its effects on cognitive function. It is not approved for human use, and should only be used by qualified researchers with appropriate safety precautions in place.